For Research Purposes Only

growth-hormoneapproved

Tesamorelin

Tesamorelin (Egrifta)

Overview

An FDA-approved GHRH analog originally for HIV-associated lipodystrophy. Increasingly used off-label for abdominal fat reduction and muscle growth. One of the few FDA-approved GH-related peptides.

Mechanism of Action

Stimulates the pituitary gland to produce and release growth hormone naturally. Unlike synthetic HGH, it works through the body's own regulatory mechanisms.

Popular Research Uses

  • Abdominal fat reduction
  • HIV lipodystrophy (approved use)
  • Muscle growth (off-label)
  • Anti-aging (off-label)
  • Cognitive function

Potential Side Effects

  • Injection site reactions
  • Joint pain
  • Swelling
  • Muscle pain
  • Paresthesia

Warnings

  • Requires prescription
  • Expensive
  • May cause fluid retention
  • Contraindicated with active malignancy
  • Monitor IGF-1 levels

Dosage Information

FDA-approved dosing. Requires prescription and medical supervision.

Research Sources

Disclaimer: This content is for research and educational purposes only. Tesamorelin is not approved for human consumption. Always consult with qualified healthcare professionals before making any decisions related to peptide research.